Search

Author/Creator Wu, Bor-Wen

1. A PHASE I EXPANSION STUDY OF PEGARGIMINASE, CISPLATIN AND PEMETREXED IN ARGININOSUCCINATE SYNTHETASE 1-NEGATIVE RECURRENT HIGH GRADE GLIOMAS (HGGS). (3rd October 2018)

Authors:
Hall, Peter; Lewis, Rachel; Syed, Nelofer; Shaffer, Richard; Evanson, Jane; Ellis, Stephen; Williams, Matthew; Feng, Xiaoxing; Johnston, Amanda; Thomson, Jim; Harris, Fiona; Jena, Raj; Jefferies, Sarah; Khadeir, Ramsay; Wu, Bor-Wen; Bomalaski, John; Crook, Timothy; Sheaff, Michael; Pacey, Simon; ...
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 5
Page Start:
v345
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers. (1st January 2021)

Authors:
Chang, Kwang-Yu; Chiang, Nai-Jung; Wu, Shang-Yin; Yen, Chia-Jui; Chen, Shang-Hung; Yeh, Yu-Min; Li, Chien-Feng; Feng, Xiaoxing; Wu, Katherine; Johnston, Amanda; Bomalaski, John S.; Wu, Bor-Wen; Gao, Jianjun; Subudhi, Sumit K.; Kaseb, Ahmed O.; Blando, Jorge M.; Yadav, Shalini S.; Szlosarek, Peter...
Journal:
Oncoimmunology
Issue:
Volume 10:Number 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search